Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Cancer Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05520619
What this trial is testing

Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)

Who this might be right for
Esophageal Squamous Cell CarcinomaLocally Advanced Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 114
Testing effectiveness (Phase 2)Study completedNCT02562729
What this trial is testing

Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer

Who this might be right for
Cervical Squamous Cell CarcinomaCervical AdenocarcinomaMalignant Neoplasm of Cervix Stage IB1+1 more
Shanghai Gynecologic Oncology Group 62
Testing effectiveness (Phase 2)UnknownNCT02004795
What this trial is testing

BNCT and IG-IMRT for Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck CancerRecurrence
Taipei Veterans General Hospital, Taiwan 28
Testing effectiveness (Phase 2)Study completedNCT00096512
What this trial is testing

S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT03087864
What this trial is testing

PDL-1 Targeting in Resectable Oesophageal Cancer

Who this might be right for
Esophageal Cancer, Stage IIEsophageal Cancer Stage III
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Not applicableStudy completedNCT05834712
What this trial is testing

Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 224
Testing effectiveness (Phase 2)Ended earlyNCT01365130
What this trial is testing

Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen

Who this might be right for
EsophagealGastrooesophageal CancerGastric Cancer
howard safran 15
Not applicableStudy completedNCT01098630
What this trial is testing

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Uterine Corpus Sarcoma+15 more
Gynecologic Oncology Group 778
Testing effectiveness (Phase 2)Looking for participantsNCT06597565
What this trial is testing

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047265
What this trial is testing

Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 164
Testing effectiveness (Phase 2)Looking for participantsNCT06970353
What this trial is testing

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

Who this might be right for
Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation
Fudan University 40
Testing effectiveness (Phase 2)Study completedNCT00137475
What this trial is testing

Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function

Who this might be right for
Head and Neck Cancer
AHS Cancer Control Alberta 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639219
What this trial is testing

T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations

Who this might be right for
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
AstraZeneca 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142421
What this trial is testing

Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
First Affiliated Hospital of Zhejiang University 35
Testing effectiveness (Phase 2)Study completedNCT00281736
What this trial is testing

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Who this might be right for
Esophageal CancerPrecancerous Condition
Roswell Park Cancer Institute 60
Testing effectiveness (Phase 2)WithdrawnNCT05668949
What this trial is testing

Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04287868
What this trial is testing

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

Who this might be right for
Cervical CancerHPV CancersAnal Cancer+2 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Study completedNCT03650764
What this trial is testing

Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine 43
Testing effectiveness (Phase 2)Study completedNCT03132038
What this trial is testing

Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck

Who this might be right for
Salivary Gland CarcinomaMetastatic CancerRecurrent Cancer
UNICANCER 98
Next Page